Meeting
2019 ASCO Annual Meeting
Cardiorespiratory fitness and cardiovascular mortality after prolonged androgen deprivation therapy for prostate cancer.
Authors
Jingyi Gong
Brigham and Women's Hospital Heart and Vascular Center, Boston, MA
Jingyi Gong , David Payne , Jesse Pittard Caron , Camden Bay , Bradley Alexander McGregor , Jon Hainer , Ann H. Partridge , Tomas G. Neilan , Marcelo Di Carli , Anju Nohria , John Groarke
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Citation
J Clin Oncol 37, 2019 (suppl; abstr 11576)
DOI
10.1200/JCO.2019.37.15_suppl.11576
Abstract #
11576
Poster Bd #
268
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Short-course hormonal therapy and the risk of death from prostate cancer in men with intermediate-risk prostate cancer undergoing high-dose radiation therapy.
First Author: Florence K. Keane
Poster
2023 ASCO Annual Meeting
Predicting absolute benefit in risk of metastasis of androgen deprivation therapy added to radiation therapy in patients with newly diagnosed prostate cancer using Prolaris.
First Author: Jonathan David Tward
Poster
2020 Genitourinary Cancers Symposium
The risk of death from prostate cancer in men with Gleason Score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy.
First Author: David Dewei Yang
Poster
2019 Genitourinary Cancers Symposium
Optimizing the use of androgen deprivation therapy in men with localized intermediate risk prostate cancer in the era of modern dose-escalated radiation therapy.
First Author: Sagar Anil Patel